Correlation of anti-viral B cell responses and splenic morphology with expression of B cell-specific molecules

International Immunology

Volumn 12, Issue 9, 2000, Pages 1275-1284

  Fehr, Thomas ^a,d   López Macías, Constantino ^a   Odermatt, Bernhard ^a   Torres, Raul M ^e   Schubart, Daniel B ^b,f   O'Keefe, Theresa L ^c,g   Matthias, Patrick ^b   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^f Axxima Pharmaceuticals AG   (Germany)

^g MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Antibody; Antiviral immunity; B cell activation; Splenic morphology

Indexed keywords

B LYMPHOCYTE RECEPTOR; BINDING PROTEIN; CD19 ANTIGEN; CD22 ANTIGEN; CELL MARKER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; OCT BINDING FACTOR; PROTEIN TYROSINE KINASE; T LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GERMINAL CENTER; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION SENSITIVITY; LYMPHOCYTE FUNCTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; VESICULAR STOMATITIS VIRUS; VIRUS NEUTRALIZATION;

EID: 0033842136     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.9.1275     Document Type: Article

References (58)

1. Transcription factors in lymphocyte development-T and B cells get together
2. The chosen few? Positive selection and the generation of naive B lymphocytes
3. Positive versus negative signaling by lymphocyte antigen receptors
4. Co-receptor and accessory regulation of B-cell antigen receptor signal transduction
5. Regulation of signalling through Blymphocyte antigen receptors by cell-cell interaction molecules
6. The B cell antigen receptor complex: Mechanisms and implications of tyrosine kinase activation
7. Transmembrane signalling by the B-cell antigen receptor
8. Signal transduction by the B cell antigen receptor and its coreceptors
9. T cell-dependent B cell activation
10. T cell independent antigens
11. B cell signalling special
12. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction?
13. T-independent activation of B cells by vesicular stomatitis virus: No evidence for the need of a second signal
14. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
15. Baculovirus expression vectors: The requirements for high level expression of proteins, including glycoproteins
16. Vaccinia virus recombinants: Expression of VSV genes and protective immunization of mice and cattle
17. Immunogenicity of a viral model vaccine after different inactivation procedures
18. Proteins of vesicular stomatitis virus: Kinetics and cellular sites of synthesis
19. Determination of total and merecaptothanol-resistant antibody in the same serum sample
20. Novel pathways of antigen presentation for the maintenance of memory
21. Induction of long-lived germinal centers associated with persisting antigen after viral infection
22. Functional analysis of T lymphocyte subsets in antiviral host defense
23. Gene targeting in the Ig kappa locus: Efficient generation of lambda chain-expressing B cells, independent of gene rearrangements in Ig kappa
24. The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus (VSV)
25. Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: Presence of an accessory cell-B cell interaction defect
26. Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection
27. Immune responses in the absence of co-stimulation: Viruses know the trick
28. Vesicular stomatitis virus Indiana glycoprotein as a T-cell- dependent and -independent antigen
29. Natural killer cells induce activated murine B cells to secrete Ig
30. Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19
31. A case for cytokines as effector molecules in the resolution of virus infection
32. Immune defence in mice lacking type I and/or type II interferon receptors
33. Hyperresponsive B cells in CD22-deficient mice
34. CD22 regulates thymus-independent responses and the lifespan of B cells
35. X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect
36. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection
37. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice
38. Mutant mice without B lymphocyte follicles
39. Antigen localisation regulates immune responses in a dose- and time- dependent fashion: A geographical view of immune reactivity
40. Microanatomy of lymphoid tissue during humoral immune responses: Structure function relationships
41. + T-cell induction and effector functions: A comparison of immunity against soluble antigens and viral infections
42. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice
43. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice
44. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation
45. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes
46. Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response
47. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice
48. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene
49. Immunity to viruses in B cell deficient mice: Influence of antibodies on virus-persistence and on T cell memory
50. Aberrant B cell development and immune response in mice with a compromised BCR complex
51. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins
52. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
53. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse
54. Btk dosage determines sensitivity to B cell antigen receptor cross- linking
55. The xid mutation diminishes memory B cell generation but does not affect somatic hypermutation and selection
56. Peritoneal Ly-1 B cells: Genetic control, autoantibody production, increased lambda light chain expression
57. B cell development in mice that lack one or both immunoglobulin kappa light chain genes